DESIGN OF HPLC METHODS OF AFOBAZOLE QUANTITATIVE ANALYSIS IN BLOOD PLASMA

Cover Page

Cite item

Full Text

Abstract

The article describes a method of quantitative analysis of anxiolytic drug with neuropro-tective activity - fabomotizole (afobazole) in rabbit blood plasma by HPLC with UV detection at 302 nm. The analysis was performed in isocratic mode using Stayer chromatography system and a reversed-phase column Phenomenex Synergi 4u Polar-RP 80A (250х4.6,4 µm) and a mobile phase (acetonitrile-water-glacial acetic acid-triethylamine in the ratio 100 : 240 : 100 : 0,3 : 0,25) at pH 6.1. The retention time of test-substance was 10,00 +/- 0,11 min. Fabomotizole extraction from plasma carried using diethyl ether (1.5 ml plasma and 6 ml acetonitrile) by shaking on Shaker apparatus at 400 vol./min for 10 minutes, centrifuging at 3500 rpm. for 10 minutes and evaporation of the supernatant on a vacuum rotary evaporator at 40 C. The recovery was 87%. The developed technique is characterized by sensitivity, specificity, ease of implementation, repro-ducibility and linearity in the plasma concentration range after oral administration of 3.8 mg of the substance (Afobazol tablets, 10 mg, Pharmstandart-Leksredstva, Russia) to rabbits.

About the authors

E N Yakusheva

Ryazan State Medical University

Author for correspondence.
Email: e.yakusheva@rzgmu.ru

Якушева Елена Николаевна, д.м.н., профессор, заведующая кафедрой фармакологии с курсом фармации ФДПО ФГБОУ ВО РязГМУ Минздрава России, г. Рязань

I V Chernih

Ryazan State Medical University

Email: e.yakusheva@rzgmu.ru

A V Shchulkin

Ryazan State Medical University

Email: e.yakusheva@rzgmu.ru

M V Gatsanoga

Ryazan State Medical University

Email: e.yakusheva@rzgmu.ru

References

  1. Avedisova A.S. Afobazol is a safe drug for the treatment of anxiety in general practice. Russian medical journal. 2006. T. 14. № 22. P. 1—3.
  2. Bochkov P.O. et al. The pharmacokinetic evaluation of a prolonged drug dosage form of afobazol in comparison with tablets of the preparation, manufactured by industry. Experimental and clinical pharmacology. 2013. P. 76. № 11. P. 33—35.
  3. Voronina T.A., Seredenin S.B. Nootropic and neuroprotective agents. Experiment-clinical pharmacology. 2007. P. 70. № 4. P. 44—58.
  4. Gatsanoga M.V., Chernykh I.V., Shchulkin A.V. et al. Is it possible to assess affiliation medicinal substances to glycoprotein-P substrates on female rabbits of Shinshilla. Science of the young (Eruditio Juvenium). 2016. Vol. 4. № 4. P. 5—10.
  5. Grushevskaya L.N., Milkina S.E., Stepanenko О.B. Pharmaceutical analysis and standartization of the solid dosage form of afobazole. Chemical-Pharmaceutical Journal cash. T. 44. № 9. P. 49—52.
  6. Toxicological chemistry metabolism and analysis of toxicants. Ed. N.I. Kaletina. Moscow: GEOTAR-MEDIA, 2008. 977 p.
  7. Epstein N.A. Assessment of fitness (validation) of HPLC techniques in the pharmaceutical analysis (review). Chemical-pharmaceutical journal. 2004. P. 38. № 4. P. 40—56.
  8. Yakusheva E.N., Chernykh I.V., Biryukova A.S. Characterization of glycoprotein-P as a protein- transporter of medicinal substances. Ros. medico-biol. known. them. acad. I.P. Pavlova. 2011. № 3. P. 142—148.
  9. Dey S., Patel J., Anand B.S. et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest. Ophtalmol. 2003. Vol. 44. № 7. P. 2909—2918.
  10. Ecker G. et al. The importance of a nitrogen atom in modulators of multidrug resistance. Mol. Pharmacol. 1999. Vol. 56. № 4. P. 791—796.
  11. El-Ela A.A. et al. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds-implications for pharmacokinetics of selected substrates. J. Pharm. Pharmacol. 2004. Vol. 56. № 8. P. 967—975.
  12. Nare B. et al. Benzimidazoles — potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochemical pharmacology. 1994. Vol. 48. No. 12. P. 2215—2222.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Yakusheva E.N., Chernih I.V., Shchulkin A.V., Gatsanoga M.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.